EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each of the Reporting Persons (as such term is defined in the Schedule 13G referred to below) by OCM XAN Holdings PT, LLC, a Delaware corporation, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.001 per share, of ACRES Therapeutics AP, a Delaware corporation, and that this agreement may be included as an exhibit to such joint filing.

Dated: August 12, 2025

	OCM XAN Holdings PT, LLC

	By:	Oaktree Capital Holdings, LLC
	Its:	Sole Managing Member

	By:	Oaktree Capital Group Holdings GP, LLC
	Its:	Indirect Owner

	By:	/s/ Henry Orren

	Name:	Henry Orren
	Title:	Authorized Signatory

	OAKTREE CAPITAL HOLDING, LLC

	By:	/s/ Brian Price

	Name:	Brian Price
	Title:	Authorized Signatory

	OAKTREE CAPITAL GROUP HOLDINGS GP, LLC

	By:	/s/ Brian Price

	Name:	Brian Price
	Title:	Authorized Signatory

ACRES Commercial Realty Corp. SCHEDULE 13G